| AXOGEN INC. DL -,01 |
| USA |
| Gesundheit |
| US05463X1063 / A1JMHK |
| LT3 (Frankfurt) / AXGN (NASDAQ) |
| FRA:LT3, ETR:LT3, LT3:GR, NASDAQ:AXGN |
| - |
| https://www.axogeninc.com.. |
|
Axogen, Inc. is a medical technology company focused on peripheral nerve regeneration and repair. Axogen develops and commercializes surgical solutions used by surgeons and healthcare providers to address nerve injuries caused by trauma, procedures, ..
>Volltext.. |
| 1993.37 Mio. EUR |
| 1910.05 Mio. EUR |
| 224.22 Mio. EUR |
| -3.36 Mio. EUR |
| -29.95 Mio. EUR |
| -0.6 EUR |
| 17.91 Mio. EUR |
| 86.21 Mio. EUR |
| 13.43 Mio. EUR |
| 3.73 |
| 23.57% |
| -619.45% |
| - |
| - |
| - |
| - |
| AXOGEN |
| 28.10.26 |
|
||||
|
||||
|
||||
|